| Patent application number | Description | Published |
|---|
| 20120068952 | USER COMPUTER DEVICE WITH TEMPERATURE SENSING CAPABILITIES AND METHOD OF OPERATING SAME - A user computer device is provided that comprises a temperature sensitive touchscreen having a temperature sensitive user interface comprising multiple thermal energy emitter/detector devices, such as thermocouples. The multiple thermal energy emitter/detector devices are capable both of detecting thermal energy and emitting thermal energy. The temperature sensitive user interface generates thermal patterns that may be transferred to other thermally sensitive electronic devices or that may be used to authenticate the user computer device. The user computer device also can detect and thermally communicate with a thermal energy docking station and, based on thermal recognition, activate applications displayed on the temperature sensitive touchscreen. Further, the user computer device can auto-bias a temperature of the temperature sensitive user interface in order to better assure proper operation of the temperature sensitive user interface in all operating conditions. | 03-22-2012 |
| 20130135220 | Active Styluses for Interacting with a Mobile Device - An active stylus or a method performed by an active stylus for interacting with a mobile device, wherein the mobile device has at least one sensor (e.g., a thermocouple junction), and wherein the stylus has at least one signal source (e.g., an analog heat source) that produces at least one signal (e.g., at least one analog temperature signal), wherein the at least one signal is configured to be detectable by the at least one sensor of the mobile device. The stylus also has at least one signal adjustment mechanism for changing the at least one signal and also has at least one transmitter (e.g., thermocouple junction) configured to transmit the at least one signal for receipt by the at least one sensor of the mobile device. | 05-30-2013 |
| 20130135262 | Mobile Device for Interacting with an Active Stylus - A mobile device or a method performed by a mobile device for interacting with a stylus, wherein the stylus has at least one sensor (e.g., a thermocouple junction), and wherein the mobile device has at least one signal source (e.g., an analog heat source) that produces at least one signal (e.g., at least one analog heat signal), wherein the at least one signal is configured to be detectable by the at least one sensor of the stylus. The mobile device also has at least one signal adjustment mechanism for changing the at least one signal and also has at least one transmitter (e.g., thermal active touch screen display) configured to transmit the at least one signal for receipt by the at least one sensor of the stylus. | 05-30-2013 |
| 20130222270 | Wearable display device, corresponding systems, and method for presenting output on the same - An electronic device can include detectors for altering the presentation of data on one or more displays. In a wearable electronic device, a flexible housing can be configured to enfold about an appendage of a user, such as a user's wrist. A display can disposed along a major face of the flexible housing. A control circuit can be operable with the display. A gaze detector can be included to detect a gaze direction, and optionally a gaze cone. An orientation detector can be configured to detect an orientation of the electronic device relative to the user. The control circuit can alter a presentation of data on the display in response to a detected gaze direction, in response to detected orientation of the wearable electronic device relative to the user, in response to touch or gesture input, or combinations thereof. Secondary displays can be hingedly coupled to the electronic device. | 08-29-2013 |
| 20140141816 | Method for Managing Notifications in a Communication Device - A method and apparatus of an electronic device for managing notifications is disclosed herewith. The method includes identifying a plurality of notifications associated with one or more electronic devices. The method further determines context data of the plurality of notifications based, at least in part, on their association with at least one remote device. The method then determines an order of display of the plurality of notifications based on the context data. The method further provides the plurality of notifications based on the order of display. | 05-22-2014 |
| 20140162482 | ELECTRICAL CONNECTOR, METHODS AND SYSTEMS THEREFOR - A connector ( | 06-12-2014 |
| Patent application number | Description | Published |
|---|
| 20080254763 | METHOD FOR MANAGING WIRELESS DEVICES USING EXCEPTION MONITORING - An improved solution for managing use of a plurality of wireless devices is provided. In an embodiment of the invention, a usage policy is obtained for the plurality of wireless devices. Usage data for one or more of the plurality of wireless devices is compared against the usage policy, wherefrom an exception report is derived and created. In another embodiment, the exception report is analyzed for non-compliance and a customer is notified. | 10-16-2008 |
| 20080254786 | MANAGING WIRELESS DEVICES USING ACCESS CONTROL - An improved solution for managing wireless devices that uses access control is provided. In an embodiment of the invention, a method for managing wireless devices includes receiving a notification for one of the plurality of wireless devices, the notification indicating at least one of: an access attempt threshold is exceeded or the wireless device is displaced; and remotely locking the wireless device based on the notification. | 10-16-2008 |
| 20080255695 | METHOD FOR MANAGING WIRELESS DEVICES USING LIFECYCLE ANALYSIS - An improved solution for managing wireless devices that uses lifecycle analysis is provided. In an embodiment of the invention, the method for managing wireless devices includes obtaining data regarding at least one new wireless device; automatically evaluating a feasibility of redeploying at least one of a plurality of pre-existing wireless devices, based on the data regarding the at least one new wireless device; and identifying a distribution for the at least one of the plurality of pre-existing wireless devices, based on the automatically evaluating. In another embodiment, the distribution may include cascading and/or retiring the pre-existing wireless device(s). | 10-16-2008 |
| Patent application number | Description | Published |
|---|
| 20080261991 | Reducing Side Effects of Tramadol - The invention provides methods of reducing the side effects of tramadol. Accordingly, in one embodiment, the invention provides a method of reducing the incidence of newly-discovered side effects related to sexual function in human males taking a tramadol material. The method comprises administering a phosphodiesterase inhibitor to a male taking the tramadol material. The invention also provides pharmaceutical compositions. In one embodiment, the composition comprises a tramadol material and a phosphodiesterase inhibitor. The invention further provides kits. In one embodiment, the kit comprises a tramadol material and a phosphodiesterase inhibitor. | 10-23-2008 |
| 20100144644 | METAL-BINDING COMPOUNDS AND USES THEREFOR - The invention provides a method of reducing the damage done by reactive oxygen species (ROS) in an animal. The invention also provides a method of reducing the concentration of a metal in an animal. These methods comprise administering to the animal an effective amount of a metal-binding compound as further described in the application. The invention further provides a method of reducing the damage done by ROS to a cell, a tissue or an organ that has been removed from an animal. This method comprising contacting the cell, tissue or organ with a solution or medium containing an effective amount of a metal-binding compound of the invention. The invention further provides novel metal-binding compounds, pharmaceutical compositions comprising the metal-binding compounds, and kits comprising a container holding a metal-binding compound of the invention. | 06-10-2010 |
| 20100249016 | METAL-BINDING COMPOUNDS AND USES THEREFOR - The invention provides a method of reducing the damage done by reactive oxygen species (ROS) in an animal. The invention also provides a method of reducing the concentration of a metal in an animal. These methods comprise administering to the animal an effective amount of a metal-binding compound as further described in the application. The invention further provides a method of reducing the damage done by ROS to a cell, a tissue or an organ that has been removed from an animal. This method comprising contacting the cell, tissue or organ with a solution or medium containing an effective amount of a metal-binding compound of the invention. The invention further provides novel metal-binding compounds, pharmaceutical compositions comprising the metal-binding compounds, and kits comprising a container holding a metal-binding compound of the invention. | 09-30-2010 |
| 20120018333 | Reducing Side Effects of Tramadol - The invention provides methods of reducing the side effects of tramadol. Accordingly, in one embodiment, the invention provides a method of reducing the incidence of newly-discovered side effects related to sexual function in human males taking a tramadol material. The method comprises administering a phosphodiesterase inhibitor to a male taking the tramadol material. The invention also provides pharmaceutical compositions. In one embodiment, the composition comprises a tramadol material and a phosphodiesterase inhibitor. The invention further provides kits. In one embodiment, the kit comprises a tramadol material and a phosphodiesterase inhibitor. | 01-26-2012 |
| 20130090292 | TREATMENT OF DEGENERATIVE JOINT DISEASE - The invention provides a method of treating a degenerative joint disease. The method comprises administering an effective amount of a pharmaceutical composition comprising a diketopiperazine with amino acid side chains of aspartic acid and alanine (DA-DKP). The invention also provides a pharmaceutical product as well as a kit comprising DA-DKP. | 04-11-2013 |
| 20130171670 | DIAGNOSIS AND MONITORING OF INFLAMMATION, ISCHEMIA AND APPENDICITIS - The invention provides methods and kits for diagnosing and monitoring inflammation and/or ischemia in an animal. The methods comprise determining the quantity of a post-translationally modified protein, other than phosphorylated tau, present in a body fluid from an animal. | 07-04-2013 |
| 20130338166 | REDUCING SIDE EFFECTS OF TRAMADOL - The invention provides methods of reducing the side effects of tramadol. Accordingly, in one embodiment, the invention provides a method of reducing the incidence of newly-discovered side effects related to sexual function in human males taking a tramadol material. The method comprises administering a phosphodiesterase inhibitor to a male taking the tramadol material. The invention also provides pharmaceutical compositions. In one embodiment, the composition comprises a tramadol material and a phosphodiesterase inhibitor. The invention further provides kits. In one embodiment, the kit comprises a tramadol material and a phosphodiesterase inhibitor. | 12-19-2013 |
| 20140256642 | TREATMENT OF DEGENERATIVE JOINT DISEASE - The invention provides a method of treating a degenerative joint disease. The method comprises administering an effective amount of a pharmaceutical composition comprising a diketopiperazine with amino acid side chains of aspartic acid and alanine (DA-DKP). The invention also provides a pharmaceutical product as well as a kit comprising DA-DKP. | 09-11-2014 |
| Patent application number | Description | Published |
|---|
| 20140050696 | NOVEL BISAMINOQUINOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS PREPARED THEREFROM AND THEIR USE - The present invention relates to novel bisaminoquinoline compounds, pharmaceutical compositions comprising these novel compounds and methods for inhibiting autophagy in biological systems. Methods of treating cancer in patients in need using compounds and/or compositions according to the present invention alone or in combination with at least one additional anticancer agent represent additional aspects of the invention. Methods of treating disease states and/or conditions in which inhibition of autophagy plays a favorable treatment role including rheumatoid arthritis, malaria, antiphospholipid antibody syndrome, lupus, chronic urticaria and Sjogren's disease, with compounds according to the present invention represent additional aspects of the invention. | 02-20-2014 |
| 20140107085 | Bifunctional AKR1C3 Inhibitors/Androgen Receptor Modulators and Methods of Use Thereof - The invention includes compositions comprising selective AKR1C3 inhibitors. The invention also includes compositions comprising bifunctional AKR1C3 inhibitors and selective androgen receptor modulators. The invention further includes methods of treatment using the compositions of the invention. | 04-17-2014 |
| 20140371228 | NOVEL THERAPEUTIC AGENTS - The present invention includes a method of treating or preventing a disease or disorder such as a mycobacterial infection, a Gram-positive bacterium infection, a yeast infection, an inflammatory condition, an auto-immune disorder and/or a proliferative disorder in a subject in need thereof. The method comprises administering to the subject a therapeutically effective amount of at least one compound of the invention, which includes clofazimine derivatives. | 12-18-2014 |
| Patent application number | Description | Published |
|---|
| 20130126515 | RADIATION SHIELDING FOR A SUBSTRATE HOLDER - A reaction chamber including a substrate supporting member positioned within the reaction chamber, the reaction chamber having a first region and a second region, a shield positioned within the second chamber and movable with the substrate supporting member, and wherein the shield is adjacent at least a bottom surface of the substrate supporting member. | 05-23-2013 |
| 20130129577 | CHAMBER SEALING MEMBER - A reaction chamber including an upper region for processing a substrate, a lower region for loading a substrate, a susceptor movable within the reaction chamber, a first sealing member positioned on a perimeter of the susceptor, a second sealing member positioned between the upper region and the lower region, wherein the first and second sealing members are selectively engaged with one another to limit communication between the upper region and the lower region. | 05-23-2013 |
| 20130230814 | SUSCEPTOR HEATER SHIM - A substrate supporting assembly in a reaction space includes a heater, a substrate support member, and a shim positioned between the heater and the substrate support member. The shim may be removably secured between the heater and the substrate support member. The shim may further include an inner surface defining a perimeter of a gap. The gap may be further defined by a bottom surface of the substrate support member and a top surface of the heater. The substrate support member may further include a shoulder positioned radially outside of a substrate support position and wherein the shim inner surface is radially aligned with the substrate support member shoulder. | 09-05-2013 |
| 20140000843 | SUSCEPTOR HEATER AND METHOD OF HEATING A SUBSTRATE | 01-02-2014 |
| Patent application number | Description | Published |
|---|
| 20110045244 | ENGINEERING FLAT SURFACES ON MATERIALS DOPED VIA PULSED LASER IRRADIATION - Methods and apparatus for processing a substrate (e.g., a semiconductor substrate) is disclosed that includes irradiating at least a portion of the substrate surface with a plurality of short radiation pulses while the surface portion is exposed to a dopant compound. The pulses are selected to have a fluence at the substrate surface that is greater than a melting fluence threshold (a minimum fluence needed for the radiation pulse to cause substrate melting) and less than an ablation fluence threshold (a minimum fluence needed for the radiation pulse to cause substrate ablation). In this manner a quantity of the dopant can be incorporated into the substrate while ensuring that the roughness of the substrate's surface is significantly less than the wavelength of the plied radiation pulses. | 02-24-2011 |
| 20110100441 | MULTIJUNCTION PHOTOVOLTAIC DEVICE - Photovoltaic devices (e.g., solar cells) are disclosed that include at least three radiation absorbing layers, each capable of absorbing radiation over a different wavelength range of the solar radiation spectrum. Any two of these three wavelength ranges can be partially overlapping, or alternatively they can be distinct. The layers are disposed relative to one another so as to form two junctions, each of which includes a depletion region. In some cases, the radiation absorbing layers can collectively absorb radiation over a wavelength range that spans at least about 60%, or 70%, or 80%, and preferably 90% of the solar radiation wavelength spectrum. By way of example, in some embodiments, one layer can exhibit significant absorption of solar radiation (e.g., it can absorb at least one radiation wavelength at an absorptance greater than about 90%) at wavelengths less than about 0.7 microns while another layer can exhibit significant absorption of the solar radiation at wavelengths in a range of about 0.7 microns to about 1 micron. The third layer can in turn exhibit a significant absorption of solar radiation at wavelengths greater than about 1 micron. | 05-05-2011 |
| Patent application number | Description | Published |
|---|
| 20130288463 | METHOD FOR PRODUCING THIN LAYERS OF CRYSTALLINE OR POLYCRYSTALLINE MATERIALS - Method for making thin crystalline or polycrystalline layers. The method includes electrochemically etching a crystalline silicon template to form a porous double layer thereon, the double layer including a highly porous deeper layer and a less porous shallower layer. The shallower layer is irradiated with a short laser pulse selected to recrystallize the shallower layer resulting in a crystalline layer. Silicon is deposited on the recrystallized shallower layer and the silicon is irradiated with a short laser pulse selected to crystalize the silicon leaving a layer of crystallized silicon on the template. Thereafter, the layer of crystallized silicon is separated from the template. The process of the invention can be used to make optoelectronic devices. | 10-31-2013 |
| 20140144497 | ATOMIC LAYER DEPOSITION FOR PHOTOVOLTAIC DEVICES - A photovoltaic device and method include a substrate, a conductive layer formed on the substrate and an absorber layer formed on the conductive layer from a Cu—Zn—Sn containing chalcogenide material. An emitter layer is formed on the absorber layer and a buffer layer is formed on the emitter layer including an atomic layer deposition (ALD) layer. A transparent conductor layer is formed on the buffer layer. | 05-29-2014 |
| 20140147958 | ATOMIC LAYER DEPOSITION FOR PHOTOVOLTAIC DEVICES - A photovoltaic device and method include a substrate, a conductive layer formed on the substrate and an absorber layer formed on the conductive layer from a Cu—Zn—Sn containing chalcogenide material. An emitter layer is formed on the absorber layer and a buffer layer is formed on the emitter layer including an atomic layer deposition (ALD) layer. A transparent conductor layer is formed on the buffer layer. | 05-29-2014 |
| 20150027521 | LOW REFLECTION ELECTRODE FOR PHOTOVOLTAIC DEVICES - A method for forming a photovoltaic device includes forming a photovoltaic absorption stack on a substrate including one or more of I-III-VI | 01-29-2015 |
| 20150059855 | TITANIUM INCORPORATION INTO ABSORBER LAYER FOR SOLAR CELL - A method for fabricating a photovoltaic device includes forming a film including titanium on a conductive layer formed on a substrate. An absorber layer is formed including a Cu—Zn—Sn containing chalcogenide compound with a kesterite structure of the formula: Cu | 03-05-2015 |
| 20150059856 | TITANIUM INCORPORATION INTO ABSORBER LAYER FOR SOLAR CELL - A method for fabricating a photovoltaic device includes forming a film including titanium on a conductive layer formed on a substrate. An absorber layer is formed including a Cu—Zn—Sn containing chalcogenide compound with a kesterite structure of the formula: Cu | 03-05-2015 |
| Patent application number | Description | Published |
|---|
| 20090076432 | Compression garment - A compression garment comprises a plurality of longitudinal yarns arranged to form a fabric having a length and generally parallel to the length, and a plurality of transverse elastomeric yarns connecting adjacent longitudinal yarns and equally spaced about a length of the longitudinal yarns. In a stretched state, the longitudinal yarns are spaced from one another and remain generally parallel to the length. | 03-19-2009 |
| 20130014544 | COMPRESSION GARMENT - A compression garment comprises a plurality of longitudinal wales arranged to form a fabric having a length and generally parallel to the length, and a plurality of secondary transverse elastomeric threads connecting adjacent longitudinal wales and equally spaced about a length of the longitudinal wales. In a stretched state, the longitudinal wales are spaced from one another and remain generally parallel to the length. | 01-17-2013 |
| 20140148742 | COMPRESSION GARMENT - A compression garment comprises a plurality of longitudinal wales arranged to form a fabric having a length and generally parallel to the length, and a plurality of secondary transverse elastomeric threads connecting adjacent longitudinal wales and equally spaced about a length of the longitudinal wales. In a stretched state, the longitudinal wales are spaced from one another and remain generally parallel to the length. | 05-29-2014 |
| Patent application number | Description | Published |
|---|
| 20080243141 | SURGICAL INSTRUMENT WITH SEPARATE TOOL HEAD AND METHOD OF USE - Surgical instruments are disclosed in which an elongated shaft is used in conjunction with a separate, remotely actuable tool head for performing a procedure on a target tissue. The shaft has a tool engagement member carried at its distal end that is remotely actuable through the shaft to engage and release the tool head. | 10-02-2008 |
| 20100305562 | Ablation Device With Cooled Electrodes And Methods of Use - An electrosurgical end effector for ablating tissue is provided that comprises at least one electrically-conductive ablation member adapted to be connected to a source of RF energy, with the ablation member having a tissue engaging surface and an internal fluid passageway. Preferably, the end effector includes two electrically conductive ablation members that are electrically isolated from one another. | 12-02-2010 |
| 20120179153 | SURGICAL INSTRUMENT WITH SEPARATE TOOL HEAD AND METHOD OF USE - Surgical instruments are disclosed in which an elongated shaft is used in conjunction with a separate, remotely actuable tool head for performing a procedure on a target tissue. The shaft has a tool engagement member carried at its distal end that is remotely actuable through the shaft to engage and release the tool head. | 07-12-2012 |
| 20140025058 | ABLATION DEVICE WITH INTERNALLY COOLED ELECTRODES - An electrosurgical end effector for ablating tissue is provided that comprises at least one electrically-conductive ablation member adapted to be connected to a source of RF energy, with the ablation member having a tissue engaging surface and defining an internal fluid passageway. Preferably, the end effector includes two electrically conductive ablation members that are electrically isolated from one another and have their fluid passageways in fluid communication. Alternatively, the end effector may comprise four electrically conductive ablation members arranged as two pairs of ablation members, all of the ablation members having internal fluid passageways that are electrically isolated from each other, with the fluid passageways of each of the four ablation members being in fluid communication with each other. | 01-23-2014 |
| 20140142597 | OCCLUSION CLIP - An occlusion clamp comprising: (a) an occlusion tongs including a primary spring coupling a first longitudinal arm to a second longitudinal arm, the first longitudinal arm including a first linear occlusion surface configured to be parallel to and overlap a second linear occlusion surface of the second longitudinal arm, each of the first and second longitudinal arms having a free distal end; and, (b) a secondary spring removably coupled to the occlusion tongs. | 05-22-2014 |
| Patent application number | Description | Published |
|---|
| 20130326038 | MANAGEMENT OF DATACENTERS FOR FAULT TOLERANCE AND BANDWIDTH - Upon receiving a request to improve one or more conditions of a datacenter network, a fault management system may analyze information of the datacenter network including communication patterns among services provided in the network. The fault management system determines one or more logical machines associated with one or more services to be moved from one or more devices to one or more other devices of the network. The fault management system may select these one or more logical machines for migration based on a cost function including factors for fault tolerance, bandwidth usage, number of moves and/or response time latency. The fault management system may improve the fault tolerance of the network without significantly affecting the bandwidth usage of the network. | 12-05-2013 |
| 20140323204 | DETERMINING GAME SKILL FACTOR - Data characterizing a quantifiable outcome for each of a plurality of game trials can be accessed. Each game trial can be associated with one of a plurality of players and a game. The game can be a digital game played on a computing platform. Using the accessed data, a first variance measure of the quantifiable outcome for all game trials associated with the plurality of players can be computed. For one or more of the plurality of players and using the accessed data, a second variance measure of the quantifiable outcome for the game trials associated with the one or more of the plurality of players can be computed. Based on at least the first variance measure and the second variance measure, a skill factor for the game can be computed. Data characterizing the skill factor can be provided. Related apparatus, systems, techniques, and articles are also described. | 10-30-2014 |
| 20150065226 | Determining Game Skill Factor - Data characterizing a quantifiable outcome for each of a plurality of game trials can be accessed. Each game trial can be associated with one of a plurality of players and a game. The game can be a digital game played on a computing platform. Using the accessed data, a first variance measure of the quantifiable outcome for all game trials associated with the plurality of players can be computed. For one or more of the plurality of players and using the accessed data, a second variance measure of the quantifiable outcome for the game trials associated with the one or more of the plurality of players can be computed. Based on at least the first variance measure and the second variance measure, a skill factor for the game can be computed. Data characterizing the skill factor can be provided. Related apparatus, systems, techniques, and articles are also described. | 03-05-2015 |
| Patent application number | Description | Published |
|---|
| 20110153105 | HOME APPLIANCE AND METHOD FOR OPERATING A HOME APPLIANCE - A home appliance includes an electronic controller with a trigger port which starts an operating cycle for the home appliance in response to a signal received on the trigger port that indicates availability of an alternative resource. | 06-23-2011 |
| 20110240060 | VARIABLE SPRAY-PATTERN IN WATER-USING CLEANING APPLIANCES - A dishwasher including a variable spray device operable to spray a liquid into a washing container of the dishwasher, the variable spray device, and a method thereof. The variable spray device may be structured to include a chamber for receiving the liquid therein, such as a dishwashing liquid or water, and a liquid deflector disposed in the chamber. The liquid deflector may have a geometrically shaped perimeter, for example, a conical shape, that allows for the generation of a centrifugal force within the chamber used in directing the spray of the liquid into the washing container. By varying a force or pressure of the liquid as it interacts with the liquid deflector in the chamber, variable spray patterns may be generated. | 10-06-2011 |
| 20110265827 | DISHWASHER WITH IMPROVED CLEANING EFFECT - A dishwasher, wherein a duct system has a function describing a pressure difference in dependence on the rotational speed of the circulating pump and having a lower rotational speed range in which the pressure difference changes at most in proportion to the rotational speed of the circulating pump and an upper rotational speed range in which the pressure difference changes more than in proportion to the rotational speed of the circulating pump; and wherein the control device has a first rinsing program in which the circulating pump is operated at a normal cleaning rotational speed for normal cleaning of the rinsing stock and a second rinsing program in which the circulating pump is operated at an intensive cleaning rotational speed higher than the normal cleaning rotational speed and lying in the upper rotational speed range for intensive cleaning of the rinsing stock. | 11-03-2011 |
| 20120230049 | HOUSEHOLD APPLIANCE INCLUDING INFORMATION LIGHT DEVICE - A household appliance including an information light device that allows a user of the household appliance to determine when the household device is in operation, and a method thereof. The information light device may include a light guide structured to indicate an operating status of the household appliance. The light guide may be disposed at a lower portion of the household appliance, and embodied as a wave guide where at least part of the light that exits the light guide is guided in a direction that is perpendicular to the light guide and onto a floor where the household appliance is disposed. | 09-13-2012 |
| Patent application number | Description | Published |
|---|
| 20130238716 | PROVIDING A COLLABORATIVE STATUS MESSAGE IN AN INSTANT MESSAGING SYSTEM - A method, system and computer program product for providing a collaborative status message in an instant messaging system. Instant Messaging (“IM”) users that belong to a group are identified. A collaborative status message (e.g., “In Meeting with User 2 and User 3”) is generated that specifies the IM users of the group (e.g., User 2 and User 3) that are participating in an event (e.g., meeting) with an IM user upon the event occurring. The collaborative status message is broadcasted to other IM users. In this manner, more detailed information can be provided to other IM users regarding the status of the IM user in question. | 09-12-2013 |
| 20130238737 | PROVIDING A COLLABORATIVE STATUS MESSAGE IN AN INSTANT MESSAGING SYSTEM - A method, system and computer program product for providing a collaborative status message in an instant messaging system. Instant Messaging (“IM”) users that belong to a group are identified. A collaborative status message (e.g., “In Meeting with User 2 and User 3”) is generated that specifies the IM users of the group (e.g., User 2 and User 3) that are participating in an event (e.g., meeting) with an IM user upon the event occurring. The collaborative status message is broadcasted to other IM users. In this manner, more detailed information can be provided to other IM users regarding the status of the IM user in question. | 09-12-2013 |
| 20130304899 | VIRTUAL MACHINE ALLOCATION AT PHYSICAL RESOURCES - Communications between virtual machines are monitored to identify virtual machines that have an affinity with each other, such as where the virtual machines have greater than a threshold of communication between each other. An affinity table tracks virtual machines having an affinity relationship and is referenced upon start-up or migration of a virtual machine so that a starting-up or migrating virtual machine will run on the same processing resource as virtual machines with which it has an affinity relationship. | 11-14-2013 |
| 20140379666 | Error Correction in Tables Using Discovered Functional Dependencies - Mechanisms are provided for performing tabular data correction in a document. Tabular data is received and analyzed to identify at least one portion of the tabular data having an erroneous/missing data value. A functional dependency of the at least one portion of the tabular data on one or more other portions of the tabular data is determined. A correct data value for the erroneous or missing data value of the at least one portion of the tabular data is determined based on the functional dependency of the at least one portion. In addition, the tabular data is modified to replace the erroneous or missing data value with the correct data value and thereby generate a modified table data. A processing operation is then performed on the modified table data to generate a resulting output. | 12-25-2014 |
| 20150046785 | Error Correction in Tables Using Discovered Functional Dependencies - Mechanisms are provided for performing tabular data correction in a document. Tabular data is received and analyzed to identify at least one portion of the tabular data having an erroneous/missing data value. A functional dependency of the at least one portion of the tabular data on one or more other portions of the tabular data is determined. A correct data value for the erroneous or missing data value of the at least one portion of the tabular data is determined based on the functional dependency of the at least one portion. In addition, the tabular data is modified to replace the erroneous or missing data value with the correct data value and thereby generate a modified table data. A processing operation is then performed on the modified table data to generate a resulting output. | 02-12-2015 |
| Patent application number | Description | Published |
|---|
| 20110157090 | MORPHING TOUCHSCREEN KEYBOARD INTERFACE - Embodiments of the present invention address deficiencies of the art in respect to touch interfaces and provide a novel and non-obvious method, system and computer program product for generating touch interface displays. In one embodiment of the invention, a computer-implemented method for generating touch interface displays at a communication device with a touch interface includes initiating a set of calibration exercises, providing a set of instructions to a user of the communication device, receiving calibration data at the touch interface, analyzing the received calibration data to determine if the calibration is complete, repeating said providing and receiving steps until the calibration is complete and generating a touch interface display based on the received calibration data. The computer-implemented method can further include receiving use data for each key touch of the touch interface, defining a set of averages over time for finger skin touch area, finger size data and finger position and automatically resizing, reshaping and repositioning at least one key of the touch interface display based on the defined set of averages. | 06-30-2011 |
| 20110161329 | TAG CLOUD BUDDY LIST FOR MESSAGING CONTACTS - Embodiments of the present invention provide a method, system and computer program product for tag cloud buddy lists. In an embodiment of the invention, a method for tag cloud buddy list management can be provided. The method can include loading a list of contacts in a messaging system executing in memory by a processor of a computer, rating each of the contacts in the list according to at least one criteria, and visually emphasizing each of the contacts differently in a buddy cloud for a user interface to the messaging system according to different ratings applied to each of the contacts. Optionally, contacts with ratings failing to exceed a threshold value can be filtered from the buddy cloud. In this regard, the threshold value can be selected with a slider control displayed in the messaging system. | 06-30-2011 |
| Patent application number | Description | Published |
|---|
| 20100041742 | RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES - It has been discovered that certain natural mRNAs serve as metabolite-sensitive genetic switches wherein the RNA directly binds a small organic molecule. This binding process changes the conformation of the mRNA, which causes a change in gene expression by a variety of different mechanisms. Modified versions of these natural “riboswitches” (created by using various nucleic acid engineering strategies) can be employed as designer genetic switches that are controlled by specific effector compounds. Such effector compounds that activate a riboswitch are referred to herein as trigger molecules. The natural switches are targets for antibiotics and other small molecule therapies. In addition, the architecture of riboswitches allows actual pieces of the natural switches to be used to construct new non-immunogenic genetic control elements, for example the aptamer (molecular recognition) domain can be swapped with other non-natural aptamers (or otherwise modified) such that the new recognition domain causes genetic modulation with user-defined effector compounds. The changed switches become part of a therapy regimen-turning on, or off, or regulating protein synthesis. Newly constructed genetic regulation networks can be applied in such areas as living biosensors, metabolic engineering of organisms, and in advanced forms of gene therapy treatments. | 02-18-2010 |
| 20100152212 | PREQ1 RIBOSWITCHES AND METHODS AND COMPOSITIONS FOR USE OF AND WITH PREQ1 RIBOSWITCHES - The preQ1 riboswitch is a target for antibiotics and other small molecule therapies. The preQ1riboswitch and portions thereof can be used to regulate the expression or function of RNA molecules and other elements and molecules. The preQ1 riboswitch and portions thereof can be used in a variety of other methods to, for example, identify or detect compounds. Compounds can be used to stimulate, active, inhibit and/or inactivate the preQ1 riboswitch. The preQ1 riboswitch and portions thereof, both alone and in combination with other nucleic acids, can be used in a variety of constructs and RNA molecules and can be encoded by nucleic acids. | 06-17-2010 |
| 20100190244 | RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES - It has been discovered that certain natural mRNAs serve as metabolite-sensitive genetic switches wherein the RNA directly binds a small organic molecule. This binding process changes the conformation of the mRNA, which causes a change in gene expression by a variety of different mechanisms. Modified versions of these natural “riboswitches” (created by using various nucleic acid engineering strategies) can be employed as designer genetic switches that are controlled by specific effector compounds. Such effector compounds that activate a riboswitch are referred to herein as trigger molecules. The natural switches are targets for antibiotics and other small molecule therapies. In addition, the architecture of riboswitches allows actual pieces of the natural switches to be used to construct new non-immunogenic genetic control elements, for example the aptamer (molecular recognition) domain can be swapped with other non-natural aptamers (or otherwise modified) such that the new recognition domain causes genetic modulation with user-defined effector compounds. The changed switches become part of a therapy regimen—turning on, or off, or regulating protein synthesis. Newly constructed genetic regulation networks can be applied in such areas as living biosensors, metabolic engineering of organisms, and in advanced forms of gene therapy treatments. | 07-29-2010 |
| 20110150854 | RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES - It has been discovered that certain natural mRNAs serve as metabolite-sensitive genetic switches wherein the RNA directly binds a small organic molecule. This binding process changes the conformation of the mRNA, which causes a change in gene expression by a variety of different mechanisms. Modified versions of these natural “riboswitches” (created by using various nucleic acid engineering strategies) can be employed as designer genetic switches that are controlled by specific effector compounds. Such effector compounds that activate a riboswitch are referred to herein as trigger molecules. The natural switches are targets for antibiotics and other small molecule therapies. In addition, the architecture of riboswitches allows actual pieces of the natural switches to be used to construct new non-immunogenic genetic control elements, for example the aptamer (molecular recognition) domain can be swapped with other non-natural aptamers (or otherwise modified) such that the new recognition domain causes genetic modulation with user-defined effector compounds. The changed switches become part of a therapy regimen—turning on, or off, or regulating protein synthesis. Newly constructed genetic regulation networks can be applied in such areas as living biosensors, metabolic engineering of organisms, and in advanced forms of gene therapy treatments. | 06-23-2011 |
| 20110151471 | RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES - It has been discovered that certain natural mRNAs serve as metabolite-sensitive genetic switches wherein the RNA directly binds a small organic molecule. This binding process changes the conformation of the mRNA, which causes a change in gene expression by a variety of different mechanisms. Modified versions of these natural “riboswitches” (created by using various nucleic acid engineering strategies) can be employed as designer genetic switches that are controlled by specific effector compounds. Such effector compounds that activate a riboswitch are referred to herein as trigger molecules. The natural switches are targets for antibiotics and other small molecule therapies. In addition, the architecture of riboswitches allows actual pieces of the natural switches to be used to construct new non-immunogenic genetic control elements, for example the aptamer (molecular recognition) domain can be swapped with other non-natural aptamers (or otherwise modified) such that the new recognition domain causes genetic modulation with user-defined effector compounds. The changed switches become part of a therapy regimen—turning on, or off, or regulating protein synthesis. Newly constructed genetic regulation networks can be applied in such areas as living biosensors, metabolic engineering of organisms, and in advanced forms of gene therapy treatments. | 06-23-2011 |
| 20110152213 | RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES - It has been discovered that certain natural mRNAs serve as metabolite-sensitive genetic switches wherein the RNA directly binds a small organic molecule. This binding process changes the conformation of the mRNA, which causes a change in gene expression by a variety of different mechanisms. Modified versions of these natural “riboswitches” (created by using various nucleic acid engineering strategies) can be employed as designer genetic switches that are controlled by specific effector compounds. Such effector compounds that activate a riboswitch are referred to herein as trigger molecules. The natural switches are targets for antibiotics and other small molecule therapies. In addition, the architecture of riboswitches allows actual pieces of the natural switches to be used to construct new non-immunogenic genetic control elements, for example the aptamer (molecular recognition) domain can be swapped with other non-natural aptamers (or otherwise modified) such that the new recognition domain causes genetic modulation with user-defined effector compounds. The changed switches become part of a therapy regimen—turning on, or off, or regulating protein synthesis. Newly constructed genetic regulation networks can be applied in such areas as living biosensors, metabolic engineering of organisms, and in advanced forms of gene therapy treatments. | 06-23-2011 |
| 20110152215 | RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES - It has been discovered that certain natural mRNAs serve as metabolite-sensitive genetic switches wherein the RNA directly binds a small organic molecule. This binding process changes the conformation of the mRNA, which causes a change in gene expression by a variety of different mechanisms. Modified versions of these natural “riboswitches” (created by using various nucleic acid engineering strategies) can be employed as designer genetic switches that are controlled by specific effector compounds. Such effector compounds that activate a riboswitch are referred to herein as trigger molecules. The natural switches are targets for antibiotics and other small molecule therapies. In addition, the architecture of riboswitches allows actual pieces of the natural switches to be used to construct new non-immunogenic genetic control elements, for example the aptamer (molecular recognition) domain can be swapped with other non-natural aptamers (or otherwise modified) such that the new recognition domain causes genetic modulation with user-defined effector compounds. The changed switches become part of a therapy regimen—turning on, or off, or regulating protein synthesis. Newly constructed genetic regulation networks can be applied in such areas as living biosensors, metabolic engineering of organisms, and in advanced forms of gene therapy treatments. | 06-23-2011 |
| 20130012527 | PREQ1 RIBOSWITCHES AND METHODS AND COMPOSITIONS FOR USE OF AND WITH PREQ1 RIBOSWITCHES | 01-10-2013 |
